Theodoros Kelesidis, M.D., Ph.D.

Internal Medicine - Infectious Diseases and Geographic Medicine
Infectious Diseases

Biography

Theodoros Kelesidis, M.D., Ph.D., is an Associate Professor in the Department of Internal Medicine at UT Southwestern Medical Center. He specializes in the treatment of infectious diseases, including HIV infection and infections in immunocompromised patients.

Originally from Greece, Dr. Kelesidis earned his medical degree at Athens University Medical School. He completed a residency in internal medicine at St. Elizabeth’s Medical Center in Boston and gained advanced training in infectious diseases through a fellowship at the University of California, Los Angeles, where he also completed a doctorate in microbiology, immunology, and molecular genetics and a master’s degree in clinical and translational research.

Certified in infectious diseases by the American Board of Internal Medicine, he joined the UT Southwestern faculty in 2023.

Dr. Kelesidis’ research focuses on infectious diseases, immunology, and cardiometabolic complications of infectious diseases, including HIV infection. His lab integrates both basic and translational research platforms to apply tools from immunology, virology, molecular biology, and medicine to understand the immunopathogenesis of infectious diseases.

He is a member of the American College of Physicians, the American Heart Association, the American Medical Association, the Infectious Diseases Society of America, and the International AIDS Society, and he serves as an Associate Editor for the journals Metabolism: Clinical and Experimental and Frontiers in Microbiology.

A frequent national and international lecturer, Dr. Kelesidis has received several awards for his research. He is the author of more than 150 original research papers and numerous book chapters, reports, and reviews.

Personal Note

When he is not at work, Dr. Kelesidis enjoys traveling and spending time with his family.

Education & Training

Medical School - University of Athens School of Health Sciences, Greece (1998-2004)
Residency - St. Elizabeth's Medical Center (2006-2009), Internal Medicine
Other Post Graduate Training - University of California Los Angeles (2011-2013)
Undergraduate School - UCLA School of Medicine (2011-2013)
Fellowship - David Geffen School of Medicine at UCLA (2009-2013), Infectious Diseases
Undergraduate School - UCLA School of Medicine (2014-2016)

Professional Associations & Affiliations

American College of Physicians
American Heart Association
American Medical Association
Infectious Diseases Society of America
International AIDS Society

Honors & Awards

First Place Award in Basic Science Competition 2018, UCLA Department of Medicine Research Day
Top Reviewers in Immunology 2018, Web of Science
Top Reviewers in Biochemistry, Genetics, and Molecular Biology 2017, Web of Science
Outstanding Problem-Based Learning Tutor Award 2014-2018, David Geffen School of Medicine at UCLA
Young Investigator Award for Oral Presentation 2012, 19th Conferences on Retroviruses and Opportunistic Infections
Program Committee Choice Award 2011, Infectious Diseases Society of America Annual Meeting
Krishnaswamy Ramaswamy, M.D. House Officer Award for the Most Outstanding Medical Resident 2009, St. Elizabeth’s Medical Center, Tufts University
Physician’s Recognition Award with Commendation in Continuing Medical Education 2007-2009, American Medical Association
Teaching Award for Excellence in Teaching of Medical Students 2008, Tufts University
Commendation for Ranking First in Class 2004-2005, Athens University Medical School

Books & Publications

Books
- Extraparenchymal neurocysticercosis in Novel Aspects on Cysticercosis and Neurocysticercosis
  Kelesidis T (2013), InTech
- Clostridium difficile in Gut Instincts: A Clinician’s Handbook of Digestive and Liver Diseases
  Kelesidis T. Pothoulakis C (2012), SLACK Incorporated
- Urinary tract immunology in Clinical Management of Complicated Urinary Tract Infection
  Kelesidis T (2011), InTech
- Central integration of environmental and endogenous signals important in the regulation of food intake and energy expenditure in Nutrition and Metabolism
  Kelesidis T, Kelesidis I, Mantzoros C (2009), Totowa, NJ, Humana Press
- Environmental inputs, intake of nutrients and endogenous molecules contributing to the regulation of energy homeostasis in Nutrition and Metabolism
  Kelesidis T, Kelesidis I, Mantzoros C (2009), Totowa, NJ, Humana Press
- The HAART induced metabolic syndrome in Obesity and Diabetes
  Tsiodras S, Kelesidis T, Mantzoros C (2005), Totawa, NJ, Humana Press
Publications
- HDL-cholesterol concentration and its association with coronary artery calcification: a systematic review and meta-analysis.
  Abedi F, Sadeghi M, Omidkhoda N, Kelesidis T, Ramezani J, Samadi S, Mohammadpour AH, Lipids in health and disease 2023 May 22 1 60
- Sleep and mood disturbances in people with HIV remain largely understudied.
  Kelesidis T, AIDS (London, England) 2023 May 37 6 993-994
- Blood immune cells from people with HIV on antiviral regimens that contain tenofovir alafenamide (TAF) and tenofovir disoproxil fumarate (TDF) have differential metabolic signatures.
  Ritou E, Satta S, Petcherski A, Daskou M, Sharma M, Vasilopoulos H, Murakami E, Shirihai OS, Kelesidis T, Metabolism: clinical and experimental 2023 Apr 141 155395
- Ectodomain shedding of proteins important for SARS-CoV-2 pathogenesis in plasma of tobacco cigarette smokers compared to electronic cigarette vapers: a cross-sectional study.
  Kelesidis T, Sharma M, Satta S, Tran E, Gupta R, Araujo JA, Middlekauff HR, Journal of molecular medicine (Berlin, Germany) 2023 Mar 101 3 327-335
- Mitoquinone Mesylate and Mitochondrial DNA in End Organs in Humanized Mouse Model of Chronic Treated Human Immunodeficiency Virus Infection.
  Song S, Satta S, Sharma MB, Hugo C, Kossyvakis A, Sen Roy S, Kelesidis T, The Journal of infectious diseases 2023 Mar
- Levels of high-density lipoprotein lipid peroxidation according to spatial socioeconomic deprivation and rurality among patients with coronary artery disease.
  Jaehn P, Sasko B, Holmberg C, Hoffmann S, Spallek J, Kelesidis T, Rapp M, Westhoff TH, Ritter O, Pagonas N, European journal of preventive cardiology 2022 Nov 29 15 e343-e346
- Mitoquinone mesylate attenuates brain inflammation in humanized mouse model of chronic HIV infection.
  Satta S, Hugo C, Sharma M, Rezek V, Kossyvakis A, Roy SS, Kitchen S, Kelesidis T, AIDS (London, England) 2022 Sep 36 11 1609-1611
- Cross-talk between SARS-CoV-2 infection and the insulin/IGF signaling pathway: Implications for metabolic diseases in COVID-19 and for post-acute sequelae of SARS-CoV-2 infection.
  Kelesidis T, Mantzoros CS, Metabolism: clinical and experimental 2022 Sep 134 155267
- Mitoquinone mesylate targets SARS-CoV-2 infection in preclinical models.
  Petcherski A, Sharma M, Satta S, Daskou M, Vasilopoulos H, Hugo C, Ritou E, Dillon BJ, Fung E, Garcia G, Scafoglio C, Purkayastha A, Gomperts BN, Fishbein GA, Arumugaswami V, Liesa M, Shirihai OS, Kelesidis T, bioRxiv : the preprint server for biology 2022 Jun
- Adipokines, Weight Gain and Metabolic and Inflammatory Markers After Antiretroviral Therapy Initiation: AIDS Clinical Trials Group (ACTG) A5260s.
  Koethe JR, Moser C, Brown TT, Stein JH, Kelesidis T, Dube M, Currier J, McComsey GA, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2022 Mar 74 5 857-864
- Instigators of COVID-19 in Immune Cells Are Increased in Tobacco Cigarette Smokers and Electronic Cigarette Vapers Compared With Nonsmokers.
  Kelesidis T, Zhang Y, Tran E, Sosa G, Middlekauff HR, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 2022 Feb 24 3 413-415
- Race and sex differences in HDL peroxide content among American adults with and without type 2 diabetes.
  Flaherty SM, Wood EK, Ryff CD, Love GD, Kelesidis T, Berkowitz L, Echeverría G, Rivera K, Rigotti A, Coe CL, Lipids in health and disease 2022 Feb 21 1 18
- The role of oxidative stress in the pathogenesis of infections with coronaviruses.
  Gain C, Song S, Angtuaco T, Satta S, Kelesidis T, Frontiers in microbiology 2022 13 1111930
- ApoA-I mimetics reduce systemic and gut inflammation in chronic treated HIV.
  Daskou M, Mu W, Sharma M, Vasilopoulos H, Heymans R, Ritou E, Rezek V, Hamid P, Kossyvakis A, Sen Roy S, Grijalva V, Chattopadhyay A, Kitchen SG, Fogelman AM, Reddy ST, Kelesidis T, PLoS pathogens 2022 Jan 18 1 e1010160
- The ApoA-I mimetic peptide 4F attenuates in vitro replication of SARS-CoV-2, associated apoptosis, oxidative stress and inflammation in epithelial cells.
  Kelesidis T, Madhav S, Petcherski A, Cristelle H, O'Connor E, Hultgren NW, Ritou E, Williams DS, Shirihai OS, Reddy ST, Virulence 2021 12 12 1 2214-2227
- Association of 1 Vaping Session With Cellular Oxidative Stress in Otherwise Healthy Young People With No History of Smoking or Vaping: A Randomized Clinical Crossover Trial.
  Kelesidis T, Tran E, Nguyen R, Zhang Y, Sosa G, Middlekauff HR, JAMA pediatrics 2021 Nov 175 11 1174-1176
- Short Communication: Plasma Lymphocyte Activation Gene 3 and Subclinical Coronary Artery Disease in the Multicenter AIDS Cohort Study.
  Sarkar S, Haberlen S, Post WS, Kelesidis T, Wiley D, Kingsley L, Kim EY, Palella FJ, Witt MD, Budoff MJ, Rodriguez A, Brown TT, AIDS research and human retroviruses 2021 Nov 37 11 842-845
- Advanced Glycation End Products Associated With Cardiometabolic Biomarkers in Treated Human Immunodeficiency Virus Infection.
  El Kamari V, Rodriguez K, Moser C, Currier JS, Kelesidis T, Stein JH, Brown TT, Howell SK, Beisswenger PJ, McComsey GA, Open forum infectious diseases 2021 Oct 8 10 ofab423
- ApoA-I mimetics favorably impact cyclooxygenase 2 and bioactive lipids that may contribute to cardiometabolic syndrome in chronic treated HIV.
  Daskou M, Sharma M, Mu W, Heymans R, Ritou E, Rezek V, Hamid P, Kossyvakis A, Sen Roy S, Grijalva V, Chattopadhyay A, Papesh J, Meriwether D, Kitchen SG, Fogelman AM, Reddy ST, Kelesidis T, Metabolism: clinical and experimental 2021 Sep 124 154888
- Electronic and Tobacco Cigarettes Alter Polyunsaturated Fatty Acids and Oxidative Biomarkers.
  Gupta R, Lin Y, Luna K, Logue A, Yoon AJ, Haptonstall KP, Moheimani RS, Choroomi Y, Nguyen K, Tran E, Zhu Y, Faull KF, Kelesidis T, Gornbein J, Middlekauff HR, Araujo JA, Circulation research 2021 Jun
- Apolipoprotein A-I mimetics attenuate macrophage activation in chronic treated HIV.
  Mu W, Sharma M, Heymans R, Ritou E, Rezek V, Hamid P, Kossyvakis A, Sen Roy S, Grijalva V, Chattopadhyay A, Papesh J, Meriwether D, Kitchen SG, Fogelman AM, Reddy ST, Kelesidis T, AIDS (London, England) 2021 03 35 4 543-553
- Update in Viral Infections in the Intensive Care Unit.
  Fragkou PC, Moschopoulos CD, Karofylakis E, Kelesidis T, Tsiodras S, Frontiers in medicine 2021 8 575580
- Expression of Key Inflammatory Proteins Is Increased in Immune Cells From Tobacco Cigarette Smokers But Not Electronic Cigarette Vapers: Implications for Atherosclerosis.
  Kelesidis T, Zhang Y, Tran E, Sosa G, Middlekauff HR, Journal of the American Heart Association 2021 Jan 10 1 e019324
- Sudden Cardiac Arrest in a Patient With Myxedema Coma and COVID-19.
  Dixit NM, Truong KP, Rabadia SV, Li D, Srivastava PK, Mosaferi T, Calfon Press MA, Donangelo I, Kelesidis T, Journal of the Endocrine Society 2020 Oct 4 10 bvaa130
- Elevated Cellular Oxidative Stress in Circulating Immune Cells in Otherwise Healthy Young People Who Use Electronic Cigarettes in a Cross-Sectional Single-Center Study: Implications for Future Cardiovascular Risk.
  Kelesidis T, Tran E, Arastoo S, Lakhani K, Heymans R, Gornbein J, Middlekauff HR, Journal of the American Heart Association 2020 Sep 9 18 e016983
- Erratum to: Changes in Bone Mineral Density After Initiation of Antiretroviral Treatment With Tenofovir Disoproxil Fumarate/Emtricitabine Plus Atazanavir/Ritonavir, Darunavir/Ritonavir, or Raltegravir.
  Brown TT, Moser C, Currier JS, Ribaudo HJ, Rothenberg J, Kelesidis T, Yang O, Dubé MP, Murphy RL, Stein JH, McComsey GA, The Journal of infectious diseases 2020 Jun 221 12 2083-2084
- Greater IL-6, D-dimer, and ICAM-1 Levels Are Associated With Lower Small HDL Particle Concentration in the Multicenter AIDS Cohort Study.
  Sarkar S, Haberlen S, Whelton S, E Schneider E, Kingsley L, Palella F, Witt MD, Kelesidis T, Rodriguez A, Post WS, Brown TT, Open forum infectious diseases 2019 Dec 6 12 ofz474
- High-density lipoprotein lipid peroxidation as a molecular signature of the risk for developing cardiovascular disease: Results from MASHAD cohort.
  Samadi S, Mehramiz M, Kelesidis T, Mobarhan MG, Sahebkar AH, Esmaily H, Moohebati M, Farjami Z, Ferns GA, Mohammadpour AH, Avan A, Journal of cellular physiology 2019 Sep 234 9 16168-16177
- The impact of aerobic and isometric exercise on different measures of dysfunctional high-density lipoprotein in patients with hypertension.
  Pagonas N, Vlatsas S, Bauer F, Seibert FS, Sasko B, Buschmann I, Ritter O, Kelesidis T, Westhoff TH, European journal of preventive cardiology 2019 Aug 26 12 1301-1309
- Lorcaserin treatment decreases body weight and reduces cardiometabolic risk factors in obese adults: A six-month, randomized, placebo-controlled, double-blind clinical trial.
  Tuccinardi D, Farr OM, Upadhyay J, Oussaada SM, Mathew H, Paschou SA, Perakakis N, Koniaris A, Kelesidis T, Mantzoros CS, Diabetes, obesity & metabolism 2019 Jun 21 6 1487-1492
- Human T lymphotropic virus type 1 and risk of cardiovascular disease: High-density lipoprotein dysfunction versus serum HDL-C concentrations.
  Samadi S, Abolbashari S, Meshkat Z, Mohammadpour AH, Kelesidis T, Gholoobi A, Mehramiz M, Tabadkani M, Sadabadi F, Dalirfardouei R, Ferns GA, Ghayour-Mobarhan M, Avan A, BioFactors (Oxford, England) 2019 May 45 3 374-380
- A Flow Cytometric Method to Determine Transfection Efficiency.
  Mu W, Homann S, Hofmann C, Gorin A, Huynh D, Yang OO, Kelesidis T, Bio-protocol 2019 May 9 10
- Brief Report: Changes in Plasma RANKL-Osteoprotegerin in a Prospective, Randomized Clinical Trial of Initial Antiviral Therapy: A5260s.
  Kelesidis T, Moser CB, Johnston E, Stein JH, Dube MP, Yang OO, McComsey GA, Currier JS, Brown TT, Journal of acquired immune deficiency syndromes (1999) 2018 Jul 78 3 362-366
- Soluble levels of receptor for advanced glycation endproducts and dysfunctional high-density lipoprotein in persons infected with human immunodeficiency virus: ACTG NWCS332.
  Kelesidis T, Kendall MA, Danoff A, Aberg JA, Currier JS, Schmidt AM, Medicine 2018 Jun 97 22 e10955
- Low Levels of Endothelial Progenitor Cells and Their Association with Systemic Inflammation and Monocyte Activation in Older HIV-Infected Men.
  Seang S, Kelesidis T, Huynh D, Park S, Moe AA, Currier JS, Lake JE, AIDS research and human retroviruses 2018 Jan 34 1 39-45
- The Role of Lipoproteins in Mycoplasma-Mediated Immunomodulation.
  Christodoulides A, Gupta N, Yacoubian V, Maithel N, Parker J, Kelesidis T, Frontiers in microbiology 2018 9 1682
- Dysfunctional high-density lipoprotein from HIV+ individuals promotes monocyte-derived foam cell formation in vitro.
  Angelovich TA, Hearps AC, Oda MN, Borja MS, Huynh D, Homann S, Jaworowski A, Kelesidis T, AIDS (London, England) 2017 Nov 31 17 2331-2336
- Quantification of Monocyte Transmigration and Foam Cell Formation from Individuals with Chronic Inflammatory Conditions.
  Angelovich TA, Hearps AC, Maisa A, Kelesidis T, Jaworowski A, Journal of visualized experiments : JoVE 2017 Oct 128
- Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein.
  Sen Roy S, Nguyen HCX, Angelovich TA, Hearps AC, Huynh D, Jaworowski A, Kelesidis T, Journal of visualized experiments : JoVE 2017 Oct 128
- Predictors of Impaired HDL Function in HIV-1 Infected Compared to Uninfected Individuals.
  Kelesidis T, Oda MN, Borja MS, Yee Y, Ng KF, Huynh D, Elashoff D, Currier JS, Journal of acquired immune deficiency syndromes (1999) 2017 Jul 75 3 354-363
- Detection of Donor-Derived Microparticles in the Peripheral Blood of a Hand Transplant Recipient During Rejection.
  Kim JY, Kelesidis T, Yang OO, Transplantation direct 2017 Mar 3 3 e131
- Rhodococcus Infection in Solid Organ and Hematopoietic Stem Cell Transplant Recipients(1).
  Vergidis P, Ariza-Heredia EJ, Nellore A, Kotton CN, Kaul DR, Morris MI, Kelesidis T, Shah H, Park SY, Nguyen MH, Razonable RR Emerging infectious diseases 2017 Mar 23 3 510-512
- Assessment of Telomere Length, Phenotype, and DNA Content.
  Kelesidis T, Schmid I, Current protocols in cytometry 2017 Jan 79 7.26.1-7.26.23
- Spirochetal Lipoproteins and Immune Evasion.
  Christodoulides A, Boyadjian A, Kelesidis T, Frontiers in immunology 2017 8 364
- γH2Ax Expression as a Potential Biomarker Differentiating between Low and High Grade Cervical Squamous Intraepithelial Lesions (SIL) and High Risk HPV Related SIL.
  Leventakos K, Tsiodras S, Kelesidis T, Kefala M, Kottaridi C, Spathis A, Gouloumi AR, Pouliakis A, Pappas A, Sioulas V, Chrelias C, Karakitsos P, Panayiotides I, PloS one 2017 12 1 e0170626
- A novel rapid and reproducible flow cytometric method for optimization of transfection efficiency in cells.
  Homann S, Hofmann C, Gorin AM, Nguyen HCX, Huynh D, Hamid P, Maithel N, Yacoubian V, Mu W, Kossyvakis A, Sen Roy S, Yang OO, Kelesidis T, PloS one 2017 12 9 e0182941
- Telmisartan increases vascular reparative capacity in older HIV-infected adults: a pilot study.
  Lake JE, Seang S, Kelesidis T, Currier JS, Yang OO, HIV clinical trials 2016 Nov 17 6 225-232
- Oxidized lipoproteins are associated with markers of inflammation and immune activation in HIV-1 infection.
  Kelesidis T, Jackson N, McComsey GA, Wang X, Elashoff D, Dube MP, Brown TT, Yang OO, Stein JH, Currier JS, AIDS (London, England) 2016 Nov 30 17 2625-2633
- Weight loss surgery in adolescents corrects high density lipoprotein subspecies and their function.
  Davidson WS, Inge TH, Sexmith H, Heink A, Elder D, Hui DY, Melchior JT, Kelesidis T, Shah AS International journal of obesity (2005) 2016 Oct
- Changes in plasma levels of oxidized lipoproteins and lipoprotein subfractions with atazanavir-, raltegravir-, darunavir-based initial antiviral therapy and associations with common carotid artery intima-media thickness: ACTG 5260s.
  Kelesidis T, Tran TT, Brown TT, Moser C, Ribaudo HJ, Dube MP, Yang OO, McComsey GA, Stein JH, Currier JS Antiviral therapy 2016 Sep
- Changes in Insulin Resistance After Initiation of Raltegravir or Protease Inhibitors With Tenofovir-Emtricitabine: AIDS Clinical Trials Group A5260s.
  Dirajlal-Fargo S, Moser C, Brown TT, Kelesidis T, Dube MP, Stein JH, Currier J, McComsey GA, Open forum infectious diseases 2016 Sep 3 3 ofw174
- Soluble Levels of Receptor for Advanced Glycation Endproducts (RAGE) and Progression of Atherosclerosis in Individuals Infected with Human Immunodeficiency Virus: ACTG NWCS 332.
  Danoff A, Kendall MA, Currier JS, Kelesidis T, Schmidt AM, Aberg JA, Inflammation 2016 Aug 39 4 1354-62
- Changes in markers of T cell senescence and exhaustion with Atazanavir-, Raltegravir-, Darunavir-Based Initial Antiviral Therapy: ACTG 5260s.
  Kelesidis T, Moser C, Stein JH, Brown TT, Tran TT, Ribaudo HJ, Dube MP, Yang OO, Currier JS, McComsey GA The Journal of infectious diseases 2016 Jun
- Body Composition Changes After Initiation of Raltegravir or Protease Inhibitors: ACTG A5260s.
  McComsey GA, Moser C, Currier J, Ribaudo HJ, Paczuski P, Dubé MP, Kelesidis T, Rothenberg J, Stein JH, Brown TT, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2016 Apr 62 7 853-62
- Indications and Types of Antibiotic Agents Used in 6 Acute Care Hospitals, 2009-2010: A Pragmatic Retrospective Observational Study.
  Kelesidis T, Braykov N, Uslan DZ, Morgan DJ, Gandra S, Johannsson B, Schweizer ML, Weisenberg SA, Young H, Cantey J, Perencevich E, Septimus E, Srinivasan A, Laxminarayan R, Infection control and hospital epidemiology 2016 Jan 37 1 70-9
- Telmisartan to reduce cardiovascular risk in older HIV-infected adults: a pilot study.
  Lake JE, Seang S, Kelesidis T, Liao DH, Hodis HN, Stein JH, Currier JS, HIV clinical trials 2015 Oct 16 5 197-206
- Changes in Bone Mineral Density After Initiation of Antiretroviral Treatment With Tenofovir Disoproxil Fumarate/Emtricitabine Plus Atazanavir/Ritonavir, Darunavir/Ritonavir, or Raltegravir.
  Brown TT, Moser C, Currier JS, Ribaudo HJ, Rothenberg J, Kelesidis T, Yang O, Dubé MP, Murphy RL, Stein JH, McComsey GA, The Journal of infectious diseases 2015 Oct 212 8 1241-9
- A prospective, randomized clinical trial of antiretroviral therapies on carotid wall thickness.
  Stein JH, Ribaudo HJ, Hodis HN, Brown TT, Tran TT, Yan M, Brodell EL, Kelesidis T, McComsey GA, Dube MP, Murphy RL, Currier JS AIDS (London, England) 2015 Sep 29 14 1775-83
- In vitro activity of daptomycin in combination with β-lactams, gentamicin, rifampin, and tigecycline against daptomycin-nonsusceptible enterococci.
  Hindler JA, Wong-Beringer A, Charlton CL, Miller SA, Kelesidis T, Carvalho M, Sakoulas G, Nonejuie P, Pogliano J, Nizet V, Humphries R, Antimicrobial agents and chemotherapy 2015 Jul 59 7 4279-88
- Changes in Inflammation and Immune Activation with Atazanavir-, Raltegravir-, Darunavir-Based Initial Antiviral Therapy: ACTG 5260s.
  Kelesidis T, Tran TT, Stein JH, Brown TT, Moser C, Ribaudo HJ, Dube MP, Murphy R, Yang OO, Currier JS, McComsey GA Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2015 Apr
- Substandard/counterfeit antimicrobial drugs.
  Kelesidis T, Falagas ME, Clinical microbiology reviews 2015 Apr 28 2 443-64
- The zoonotic potential of daptomycin non-susceptible enterococci.
  Kelesidis T, Zoonoses and public health 2015 Feb 62 1 1-6
- The Role of Platelet-Activating Factor in Chronic Inflammation, Immune Activation, and Comorbidities Associated with HIV Infection.
  Kelesidis T, Papakonstantinou V, Detopoulou P, Fragopoulou E, Chini M, Lazanas MC, Antonopoulou S, AIDS reviews 2015 17 4 191-201
- First Report of Ventriculoperitoneal Shunt Infection due to Cyberlindnera fabianii.
  Baghdadi J, Hemarajata P, Humphries R, Kelesidis T, Case reports in infectious diseases 2015 2015 630816
- The safety of polymyxin antibiotics.
  Kelesidis T, Falagas ME, Expert opinion on drug safety 2015 14 11 1687-701
- Assessment of empirical antibiotic therapy optimisation in six hospitals: an observational cohort study.
  Braykov NP, Morgan DJ, Schweizer ML, Uslan DZ, Kelesidis T, Weisenberg SA, Johannsson B, Young H, Cantey J, Srinivasan A, Perencevich E, Septimus E, Laxminarayan R, The Lancet. Infectious diseases 2014 Dec 14 12 1220-7
- How to approach and treat viral infections in ICU patients.
  Kelesidis T, Mastoris I, Metsini A, Tsiodras S, BMC infectious diseases 2014 Nov 14 321
- Immunomodulation of antiretroviral drug-suppressed chronic HIV-1 infection in an oral probiotic double-blind placebo-controlled trial.
  Yang OO, Kelesidis T, Cordova R, Khanlou H, AIDS research and human retroviruses 2014 Oct 30 10 988-95
- Dyslipidemia and cardiovascular risk in human immunodeficiency virus infection.
  Kelesidis T, Currier JS, Endocrinology and metabolism clinics of North America 2014 Sep 43 3 665-84
- Mechanisms of linezolid resistance among coagulase-negative staphylococci determined by whole-genome sequencing.
  Tewhey R, Gu B, Kelesidis T, Charlton C, Bobenchik A, Hindler J, Schork NJ, Humphries RM, mBio 2014 May 5 3 e00894-14
- HDL redox activity is increased in HIV-infected men in association with macrophage activation and noncalcified coronary atherosclerotic plaque.
  Zanni MV, Kelesidis T, Fitzgerald ML, Lo J, Abbara S, Wai B, Marmarelis E, Hernandez NJ, Yang OO, Currier JS, Grinspoon SK Antiviral therapy 2014 Feb
- Proximity to animal or crop operations may be associated with de novo daptomycin-non-susceptible Enterococcus infection.
  Kelesidis T, Chow AL, Epidemiology and infection 2014 Jan 142 1 221-4
- Role of RANKL-RANK/osteoprotegerin pathway in cardiovascular and bone disease associated with HIV infection.
  Kelesidis T, Currier JS, Yang OO, Brown TT, AIDS reviews 2014 16 3 123-33
- The Cross-Talk between Spirochetal Lipoproteins and Immunity.
  Kelesidis T, Frontiers in immunology 2014 5 310
- The Interplay between Daptomycin and the Immune System.
  Kelesidis T, Frontiers in immunology 2014 5 52
- A high throughput biochemical fluorometric method for measuring lipid peroxidation in HDL.
  Kelesidis T, Roberts CK, Huynh D, Martínez-Maza O, Currier JS, Reddy ST, Yang OO, PloS one 2014 9 11 e111716
- Frequency of susceptibility testing for patients with persistent methicillin-resistant Staphylococcus aureus bacteremia.
  Giltner CL, Kelesidis T, Hindler JA, Bobenchik AM, Humphries RM, Journal of clinical microbiology 2014 Jan 52 1 357-61
- Transport of daptomycin resistance genes between animals and humans as a possible mechanism for development of de novo daptomycin resistance in enterococci.
  Kelesidis T, Epidemiology and infection 2013 Oct 141 10 2185-6
- Untrained young men have dysfunctional HDL compared with strength-trained men irrespective of body weight status.
  Roberts CK, Katiraie M, Croymans DM, Yang OO, Kelesidis T, Journal of applied physiology (Bethesda, Md. : 1985) 2013 Oct 115 7 1043-9
- Evolution of high-level daptomycin resistance in Enterococcus faecium during daptomycin therapy is associated with limited mutations in the bacterial genome.
  Kelesidis T, Tewhey R, Humphries RM, The Journal of antimicrobial chemotherapy 2013 Aug 68 8 1926-8
- Emergence of daptomycin-non-susceptible enterococci urinary tract isolates.
  Kelesidis T, Humphries R, Chow ALP, Tsiodras S, Uslan DZ, Journal of medical microbiology 2013 Jul 62 Pt 7 1103-1105
- Perturbations of circulating levels of RANKL-osteoprotegerin axis in relation to lipids and progression of atherosclerosis in HIV-infected and -uninfected adults: ACTG NWCS 332/A5078 Study.
  Kelesidis T, Kendall MA, Yang OO, Hodis H, Currier JS, AIDS research and human retroviruses 2013 Jun 29 6 938-48
- Dysfunctional HDL and progression of atherosclerosis in HIV-1-infected and -uninfected adults.
  Kelesidis T, Yang OO, Kendall MA, Hodis HN, Currier JS, Lipids in health and disease 2013 Mar 12 23
- The emerging problem of linezolid-resistant Staphylococcus.
  Gu B, Kelesidis T, Tsiodras S, Hindler J, Humphries RM, The Journal of antimicrobial chemotherapy 2013 Jan 68 1 4-11
- Biomarkers of microbial translocation and macrophage activation: association with progression of subclinical atherosclerosis in HIV-1 infection.
  Kelesidis T, Kendall MA, Yang OO, Hodis HN, Currier JS, The Journal of infectious diseases 2012 Nov 206 10 1558-67
- Genotypic and phenotypic evaluation of the evolution of high-level daptomycin nonsusceptibility in vancomycin-resistant Enterococcus faecium.
  Humphries RM, Kelesidis T, Tewhey R, Rose WE, Schork N, Nizet V, Sakoulas G, Antimicrobial agents and chemotherapy 2012 Nov 56 11 6051-3
- Successful treatment of azole-resistant Candida spondylodiscitis with high-dose caspofungin monotherapy.
  Kelesidis T, Tsiodras S, Rheumatology international 2012 Sep 32 9 2957-8
- Extraparenchymal neurocysticercosis in the United States.
  Kelesidis T, Tsiodras S, The American journal of the medical sciences 2012 Jul 344 1 79-82
- Effects of lipid-probe interactions in biochemical fluorometric methods that assess HDL redox activity.
  Kelesidis T, Reddy ST, Huynh D, Meriwether D, Fogelman AM, Navab M, Yang OO, Lipids in health and disease 2012 Jul 11 87
- Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in Los Angeles County.
  Kelesidis T, Humphries R, Terashita D, Eshaghian S, Territo MC, Said J, Lewinski M, Currier JS, Pegues D, Journal of medical virology 2012 May 84 5 777-85
- De novo daptomycin-nonsusceptible enterococcal infections.
  Kelesidis T, Humphries R, Uslan DZ, Pegues D, Emerging infectious diseases 2012 Apr 18 4 674-6
- Case-control study comparing de novo and daptomycin-exposed daptomycin-nonsusceptible Enterococcus infections.
  Kelesidis T, Chow AL, Humphries R, Uslan DZ, Pegues D, Antimicrobial agents and chemotherapy 2012 Apr 56 4 2150-2
- Efficacy and safety of the probiotic Saccharomyces boulardii for the prevention and therapy of gastrointestinal disorders.
  Kelesidis T, Pothoulakis C, Therapeutic advances in gastroenterology 2012 Mar 5 2 111-25
- Comment on: Successful therapy of treatment-emergent, non-clonal daptomycin-non-susceptible Enterococcus faecium infections.
  Kelesidis T, The Journal of antimicrobial chemotherapy 2012 Feb 67 2 515-6
- An unusual cutaneous tumor: African histoplasmosis following mudbaths: case report and review.
  Tsiodras S, Drogari-Apiranthitou M, Pilichos K, Leventakos K, Kelesidis T, Buitrago MJ, Petrikkos G, Panayiotides I, The American journal of tropical medicine and hygiene 2012 Feb 86 2 261-3
- Gastrointestinal symptoms among ambulatory HIV patients: appropriate symptom management requires improved symptom recognition.
  Kelesidis T, Annals of gastroenterology 2012 25 3 186-187
- A biochemical fluorometric method for assessing the oxidative properties of HDL.
  Kelesidis T, Currier JS, Huynh D, Meriwether D, Charles-Schoeman C, Reddy ST, Fogelman AM, Navab M, Yang OO, Journal of lipid research 2011 Dec 52 12 2341-2351
- Combination therapy with daptomycin, linezolid, and rifampin as treatment option for MRSA meningitis and bacteremia.
  Kelesidis T, Humphries R, Ward K, Lewinski MA, Yang OO, Diagnostic microbiology and infectious disease 2011 Nov 71 3 286-90
- Extraparenchymal neurocysticercosis in the United States: a case report.
  Kelesidis T, Tsiodras S, Journal of medical case reports 2011 Aug 5 359
- Human papillomavirus (HPV) detection using in situ hybridization in histologic samples: correlations with cytologic changes and polymerase chain reaction HPV detection.
  Kelesidis T, Aish L, Steller MA, Aish IS, Shen J, Foukas P, Panayiotides J, Petrikkos G, Karakitsos P, Tsiodras S, American journal of clinical pathology 2011 Jul 136 1 119-27
- Establishing diagnosis of Haemophilus parainfluenzae as etiology of culture-negative endocarditis using DNA sequence analysis on tissue specimen.
  Kelesidis T, Kelesidis I, Lewinski MA, Humphries R, The American journal of medicine 2011 Jul 124 7 e9-e10
- Multiple intraventricular neurocysticercal cysts treated with endoscopy without antiparasitic therapy.
  Kelesidis T, Thian N, The American journal of tropical medicine and hygiene 2011 Jul 85 1 1-2
- Preexposure prophylaxis for HIV prevention.
  Kelesidis T, Landovitz RJ, Current HIV/AIDS reports 2011 Jun 8 2 94-103
- Hypopituitarism caused by neurocysticercosis.
  Kelesidis T, Tsiodras S, The American journal of the medical sciences 2011 May 341 5 414-6
- Bloodstream infection with Anaerobiospirillum succiniciproducens: a potentially lethal infection.
  Kelesidis T, Southern medical journal 2011 Mar 104 3 205-14
- HIV-1 infected patients with suppressed plasma viremia on treatment have pro-inflammatory HDL.
  Kelesidis T, Yang OO, Currier JS, Navab K, Fogelman AM, Navab M, Lipids in health and disease 2011 Feb 10 35
- Correction:Acquired hemophilia as the cause of life-threatening hemorrhage in a 94-year-old man: a case report.
  Kelesidis T, Raphael J, Blanchard E, Journal of medical case reports 2011 Feb 5 73
- Daptomycin nonsusceptible enterococci: an emerging challenge for clinicians.
  Kelesidis T, Humphries R, Uslan DZ, Pegues DA, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2011 Jan 52 2 228-34
- Does rituximab increase the incidence of infectious complications? A narrative review.
  Kelesidis T, Daikos G, Boumpas D, Tsiodras S, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2011 Jan 15 1 e2-16
- Clostridium sphenoides bloodstream infection in man.
  Kelesidis T, Tsiodras S, Emerging infectious diseases 2011 Jan 17 1 156-8
- Smooth muscle tumour of the right groin: description of a unique case.
  Kelesidis T, Irish journal of medical science 2010 Dec 179 4 603-4
- Successful treatment of pan-resistant Klebsiella pneumoniae pneumonia and bacteraemia with a combination of high-dose tigecycline and colistin.
  Humphries RM, Kelesidis T, Dien Bard J, Ward KW, Bhattacharya D, Lewinski MA, Journal of medical microbiology 2010 Nov 59 Pt 11 1383-1386
- Staphylococcus intermedius is not only a zoonotic pathogen, but may also cause skin abscesses in humans after exposure to saliva.
  Kelesidis T, Tsiodras S, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2010 Oct 14 10 e838-41
- Maternal diet and cord blood leptin and adiponectin concentrations at birth.
  Mantzoros CS, Sweeney L, Williams CJ, Oken E, Kelesidis T, Rifas-Shiman SL, Gillman MW, Clinical nutrition (Edinburgh, Scotland) 2010 Oct 29 5 622-6
- Acquired hemophilia as the cause of life-threatening hemorrhage in a 94-year-old man: a case report.
  Kelesidis T, Raphael J, Blanchard E, Parameswaran R, Journal of medical case reports 2010 Jul 4 231
- Interleukin-2-unresponsive immune defects in good syndrome: Letter to the Editor.
  Yang OO, Kelesidis T, Clinical immunology (Orlando, Fla.) 2010 Jun 135 3 496-8
- Good's syndrome remains a mystery after 55 years: A systematic review of the scientific evidence.
  Kelesidis T, Yang O, Clinical immunology (Orlando, Fla.) 2010 Jun 135 3 347-63
- First report of treatment of Anaerobiospirillum succiniciproducens bloodstream infection with levofloxacin.
  Kelesidis T, Dien Bard J, Humphries R, Ward K, Lewinski MA, Uslan DZ, Journal of clinical microbiology 2010 May 48 5 1970-3
- Listeria endocarditis in a patient with psoriatic arthritis on infliximab: are biologic agents as treatment for inflammatory arthritis increasing the incidence of Listeria infections?
  Kelesidis T, Salhotra A, Fleisher J, Uslan DZ, The Journal of infection 2010 May 60 5 386-96
- An unusual foreign body as cause of chronic sinusitis: a case report.
  Kelesidis T, Osman S, Dinerman H, Journal of medical case reports 2010 May 4 157
- Cytomegalovirus pseudotumor of the duodenum in a patient with AIDS: an unrecognized and potentially treatable clinical entity.
  Kelesidis T, Tozzi S, Mitty R, Worthington M, Fleisher J, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2010 Apr 14 4 e274-82
- Anaphylactoid reaction considered ciprofloxacin related: a case report and literature review.
  Kelesidis T, Fleisher J, Tsiodras S, Clinical therapeutics 2010 Mar 32 3 515-26
- Giant right atrium with severe pulmonary hypertension.
  Kelesidis T, Maysky M, Kelesidis I, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2010 Feb 182 3 E147
- Giant inguinoscrotal hernia as a cause of hydronephrosis.
  Kelesidis T, Canseco E, The American journal of the medical sciences 2010 Feb 339 2 174
- Quinolone-induced hypoglycemia: a life-threatening but potentially reversible side effect.
  Kelesidis T, Canseco E, The American journal of medicine 2010 Feb 123 2 e5-6
- Tracheobronchitis caused by methicillin-resistant Staphylococcus aureus as a cause of chronic wheezing in a non-ventilated adult patient with tracheobronchomalacia.
  Kelesidis T, Osman S, Trayner E, Worthington M, Celli B, Respiration; international review of thoracic diseases 2010 80 2 148-56
- Candida albicans prosthetic hip infection in elderly patients: is fluconazole monotherapy an option?
  Kelesidis T, Tsiodras S, Scandinavian journal of infectious diseases 2010 42 1 12-21
- Narrative review: the role of leptin in human physiology: emerging clinical applications.
  Kelesidis T, Kelesidis I, Chou S, Mantzoros CS, Annals of internal medicine 2010 Jan 152 2 93-100
- Unexplained high fever in an elderly patient treated with clonidine, duloxetine, and atorvastatin.
  Kelesidis T, Kelesidis I, Clinical therapeutics 2009 Dec 31 12 2894-9
- Postirradiation Klebsiella pneumoniae-associated necrotizing fasciitis in the western hemisphere: a rare but life-threatening clinical entity.
  Kelesidis T, Tsiodras S, The American journal of the medical sciences 2009 Sep 338 3 217-24
- Emphysematous cystitis in the absence of known risk factors: an unusual clinical entity.
  Kelesidis T, Osman S, Tsiodras S, Southern medical journal 2009 Sep 102 9 942-6
- Perineurioma of esophagus: a first case report.
  Kelesidis T, Tarbox A, Lopez M, Aish L, The American journal of the medical sciences 2009 Sep 338 3 230-2
- Levofloxacin-induced hypoglycemia: a rare but life-threatening side effect of a widely used antibiotic.
  Kelesidis T, Canseco E, The American journal of medicine 2009 Mar 122 3 e3-4
- Cord blood leptin and adiponectin as predictors of adiposity in children at 3 years of age: a prospective cohort study.
  Mantzoros CS, Rifas-Shiman SL, Williams CJ, Fargnoli JL, Kelesidis T, Gillman MW, Pediatrics 2009 Feb 123 2 682-9
- Tigecycline for the treatment of multidrug-resistant Enterobacteriaceae: a systematic review of the evidence from microbiological and clinical studies.
  Kelesidis T, Karageorgopoulos DE, Kelesidis I, Falagas ME, The Journal of antimicrobial chemotherapy 2008 Nov 62 5 895-904
- Tigecycline for the treatment of multidrug-resistant (including carbapenem-resistant) Acinetobacter infections: a review of the scientific evidence.
  Karageorgopoulos DE, Kelesidis T, Kelesidis I, Falagas ME, The Journal of antimicrobial chemotherapy 2008 Jul 62 1 45-55
- Isolation and characterization of a novel Francisella sp. from human cerebrospinal fluid and blood.
  Kugeler KJ, Mead PS, McGowan KL, Burnham JM, Hogarty MD, Ruchelli E, Pollard K, Husband B, Conley C, Rivera T, Kelesidis T, Lee WM, Mabey W, Winchell JM, Stang HL, Staples JE, Chalcraft LJ, Petersen JM Journal of clinical microbiology 2008 Jul 46 7 2428-31
- Axillary abscess in a patient with Yersinia enterocolitica infection as a result of exposure to pork.
  Kelesidis T, Balba G, Worthington M, The American journal of medicine 2008 Mar 121 3 e1
- Human infections associated with wild birds.
  Tsiodras S, Kelesidis T, Kelesidis I, Bauchinger U, Falagas ME, The Journal of infection 2008 Feb 56 2 83-98
- Community-acquired Acinetobacter infections.
  Falagas ME, Karveli EA, Kelesidis I, Kelesidis T, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2007 Dec 26 12 857-68
- Counterfeit or substandard antimicrobial drugs: a review of the scientific evidence.
  Kelesidis T, Kelesidis I, Rafailidis PI, Falagas ME, The Journal of antimicrobial chemotherapy 2007 Aug 60 2 214-36
- Plasma adiponectin concentrations and risk of incident breast cancer.
  Tworoger SS, Eliassen AH, Kelesidis T, Colditz GA, Willett WC, Mantzoros CS, Hankinson SE, The Journal of clinical endocrinology and metabolism 2007 Apr 92 4 1510-6
- Regulation of adiponectin and its receptors in response to development of diet-induced obesity in mice.
  Bullen JW, Bluher S, Kelesidis T, Mantzoros CS, American journal of physiology. Endocrinology and metabolism 2007 Apr 292 4 E1079-86
- Total and high-molecular-weight adiponectin in breast cancer: in vitro and in vivo studies.
  Körner A, Pazaitou-Panayiotou K, Kelesidis T, Kelesidis I, Williams CJ, Kaprara A, Bullen J, Neuwirth A, Tseleni S, Mitsiades N, Kiess W, Mantzoros CS, The Journal of clinical endocrinology and metabolism 2007 Mar 92 3 1041-8
- Growth hormone-binding protein is directly and IGFBP-3 is inversely associated with risk of female breast cancer.
  Pazaitou-Panayiotou K, Kelesidis T, Kelesidis I, Kaprara A, Blakeman J, Vainas I, Mpousoulegas A, Williams CJ, Mantzoros C, European journal of endocrinology 2007 Feb 156 2 187-94
- Total and high-molecular weight adiponectin in relation to metabolic variables at baseline and in response to an exercise treatment program: comparative evaluation of three assays.
  Blüher M, Brennan AM, Kelesidis T, Kratzsch J, Fasshauer M, Kralisch S, Williams CJ, Mantzoros CS, Diabetes care 2007 Feb 30 2 280-5
- Adiponectin and cancer: a systematic review.
  Kelesidis I, Kelesidis T, Mantzoros CS, British journal of cancer 2006 May 94 9 1221-5
- The emerging role of leptin in humans.
  Kelesidis T, Mantzoros CS, Pediatric endocrinology reviews : PER 2006 Mar 3 3 239-48
- Mycoplasma pneumoniae-associated myelitis: a comprehensive review.
  Tsiodras S, Kelesidis T, Kelesidis I, Voumbourakis K, Giamarellou H, European journal of neurology 2006 Feb 13 2 112-24
- Peptide YY levels are decreased by fasting and elevated following caloric intake but are not regulated by leptin.
  Chan JL, Stoyneva V, Kelesidis T, Raciti P, Mantzoros CS, Diabetologia 2006 Jan 49 1 169-73
- Central nervous system manifestations of Mycoplasma pneumoniae infections.
  Tsiodras S, Kelesidis I, Kelesidis T, Stamboulis E, Giamarellou H, The Journal of infection 2005 Dec 51 5 343-54

Research

Cardiometabolic disease
End organ disease associated with viral infections
HIV-associated cardiometabolic disease
Host-pathogen interactions
Immunology
Immunopathogenesis of HIV infection
Inflammation
Oxidative stress
Toxicity of antiretroviral therapy

Clinical Focus

Infectious Diseases